Toggle Health Problems and D

COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D) - Jan 2022

Characteristics of COVID-19 in patients with multiple sclerosis - Jan 2022

Multiple Sclerosis and Related Disorders 57 (2022) 103437 - Authors from Iran https://doi.org/10.1016/j.msard.2021.103437

Study obeserved, but did not comment on the fact that
   85% of MSers were taking Vitamin D


Background: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study
Multiple rclercste of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.

Methods: Data on MS patients with COVID-19 from nine provinces of Iran were entered in a web-based registry system, between July 2020 and March 2021. Among the COVID-19 symptoms, dyspnea, altered mental status, or those resulting in hospital admission were considered severe.

Results: A total of 397 eligible patients were identified. In addition, 310 (78%) were female. The mean age was 36.5 ± 9.5. 294 (74%) patients had relapsing- remitting form. Also, four patients (1%) expired due to COVID-19 infection. The mean duration of admission in hospitalized patients was 9 (± 5.3) days. MRI was performed on 111 (28%) patients after developing COVID-19. MRI changes were observed in 27 (24%) of these cases. MS drug was changed in 26 (6%) patients. Steroid use in the past three months (OR: 2.43, 95% CI: 1.003-5.88) (p value: 0.049) and antiCD20s (OR: 4.03, 95% CI: 2.41-6.68) (p value < 0.001) showed significant association with severe COVID-19 symptoms.

Conclusion: The death rate of COVID-19 among MS patients (1%) is lower than the overall death rate of the pandemic in Iran (3%). Those who received steroid in the past three months may be at increased risk of more severe forms of COVID-19. There are still doubts about the effect of anti CD20s on COVID-19 severity.
 Download the PDF from VitaminDWiki

VitaminDWiki - Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D) – April 30, 2021

VitaminDWiki - MS updates from Brazil

VitaminDWiki - Multiple Sclerosis 32 percent less likely among those with more than 32 ng of vitamin D – Dec 2019 contains

UV and Sunshine reduces MS risk

Other things also help

High Dose Vitamin D and cofactors

Number of MS studies which are also in other categories

  • 22 studies in Genetics - genes can restrict Vitamin D getting to the blood and to the cells
  • 12 studies in Vitamin D Receptor - gene which restricts D from getting to the cells
  • 7 studies in Vitamin D Binding Protein - gene which restricts D from getting to the cells
  • 21 studies in Ultraviolet light - may be even better than Vitamin D in preventing and treating MS
  • 9 studies in Omega-3 - which helps Vitamin D prevent and treat MS

Created by admin. Last Modification: Wednesday January 12, 2022 15:22:26 GMT-0000 by admin. (Version 10)

Attached files

ID Name Comment Uploaded Size Downloads
16878 MS COVID.jpg admin 12 Jan, 2022 23.17 Kb 283
16877 COVID MS.pdf admin 12 Jan, 2022 353.75 Kb 254